A Study to Test the Effects and Safety of Palopegteriparatide in Adolescents With Long-term Hypoparathyroidism

NCT07706764 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoparathyroidism

Interventions

COMBINATION_PRODUCT: Palopegteriparatide

Sponsor

Ascendis Pharma A/S